ArticleToxics2026
Evaluation of Immunotoxicity Induced by Organophosphorus Pesticide Malathion.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Green synthesis and application of ZnO nanoparticles for removing malathion and pyrene from aqueous solutions.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Malathion (MLT) is an organophosphate pesticide widely used worldwide. Due to its environmental persistence and accumulation in living organisms, concerns have been raised regarding its potential health effects beyond the classical mechanism of cholinergic inhibition, particularly its impact on immune function. In this study, we aimed to systematically evaluate the immunotoxicity of MLT in mice and identify the lowest-observed-adverse-effect level (LOAEL) for immunotoxic effects. Key parameters assessed included body and organ weights, hematological and clinical chemistry profiles, histopathological changes, and immune function indicators. The results showed that exposure to MLT, particularly at low and intermediate doses, led to a significant increase in thymus weight, along with marked reductions in interleukin-10 (IL-10) levels, neutrophils, polychromatic erythroblasts, and monocyte lineage cells. Histological examination revealed atrophy of splenic white pulp, indicating immunopathological alterations predominantly at these dose levels. In contrast, immunoglobulin G (IgG) levels increased in a dose-dependent manner, possibly reflecting a compensatory humoral response to the observed suppression of cellular immune components. Meanwhile, the plaque-forming cell (PFC) response exhibited a dose-dependent trend but was significantly inhibited only at the highest dose, suggesting a complex, non-linear effect on humoral immunity. Based on significant alterations in thymus weight, cellular immune parameters, and splenic histopathology observed at the lowest dose tested (16 mg/kg bw), this value was preliminarily identified as the LOAEL for MLT-induced immunotoxicity in mice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.